Corpus Intelligence IC Memo — HUTCHINSON HEALTH CARE 2026-04-26 03:50 UTC
IC Memo — HUTCHINSON HEALTH CARE
Investment Committee Memorandum | MN | 37 beds | Grade C | EBITDA uplift $6.6M
🛡️ Public data only — no PHI permitted on this instance.
Investment Committee Memorandum

HUTCHINSON HEALTH CARE

CCN 240187 | MC LEOD, MN | 37 beds | April 26, 2026
EBITDA BridgeData Room
C
Investability

1. Target Overview & Investment Thesis

HUTCHINSON HEALTH CARE is a 37-bed suburban community hospital in MC LEOD, MN with $89.5M in net patient revenue and a -1.7% operating margin. The hospital serves a payer mix of 27.2% Medicare, 7.8% Medicaid, and 65.0% commercial.

Thesis: Turnaround. Our ML models identify $6.6M in annual EBITDA improvement potential from RCM optimization across 5 levers, lifting margin from -1.7% to 5.7% (+736bps).

Net Revenue HCRIS$89.5M
Current EBITDA COMPUTED$-1.5M
Operating Margin COMPUTED-1.7%
Occupancy HCRIS48.3%
Revenue / Bed COMPUTED$2.4M
Net-to-Gross HCRIS43.1%
Distress Probability ML48.9%

2. Market Context & Competitive Position

141
MN Hospitals
-3.6%
State Median Margin
64
Comparable Hospitals

MN has 141 Medicare-certified hospitals with a median operating margin of -3.6%. The target's margin of -1.7% places it above the state median. Among 64 size-comparable peers (18-74 beds), the median margin is -3.1%. The target performs in line with or above peers.

3. RCM Performance Analysis — Comparable Hospitals

Comps selected by bed count (18-74), prioritizing same-state peers. 64 hospitals in the comp set.

HospitalStateBedsRevenueMargin
HUTCHINSON HEALTH CARE (Target)MN37$89.5M-1.7%
LAKEVIEW MEMORIALMN68$411.9M60.9%
GILLETTE CHILDRENS SPECIALTY HMN60$266.7M-6.3%
OLMSTED MEDICAL CENTERMN61$217.6M-13.6%
CUYUNA REGIONAL MEDICAL CENTERMN25$180.8M-4.0%
ST. MARYS REGIONAL HEALTH CENTMN36$167.8M3.1%
MAYO CLINIC HEALTH SYSTEM - REMN27$149.3M1.8%
ESSENTIA HEALTH VIRGINIAMN49$132.0M-5.0%
NEW ULM MEDICAL CENTERMN24$128.6M4.2%

4. Predicted Improvement Opportunities

Improvement targets set at P75 of comparable peers with 60% gap closure assumption. Coefficients calibrated to published research bands. Total EBITDA uplift: $6.6M (736bps margin improvement).

LeverCurrentTargetEBITDA ImpactMarginRamp
Net Collection Rate93.5%97.0%$1.9M+210bp18mo
Cost to Collect4.5%2.5%$1.8M+200bp12mo
Denial Rate Reduction12.0%6.5%$1.8M+198bp12mo
A/R Days Reduction5200.0%3800.0%$1.1M+122bp9mo
Clean Claim Rate88.0%96.0%$57K+6bp6mo

5. EBITDA Bridge

Net Collection Rate
$1.9M
Cost to Collect
$1.8M
Denial Rate Reduction
$1.8M
A/R Days Reduction
$1.1M
Clean Claim Rate
$57K
Total EBITDA Uplift$6.6M
Current EBITDA$-1.5M
+ RCM Uplift+$6.6M
Pro Forma EBITDA$5.1M
Current Margin-1.7%
Pro Forma Margin5.7%
WC Released (1x)$3.4M

6. Returns Analysis — Scenario Matrix

5-year hold, 5.5x leverage, 3% organic growth, 10%/yr debt paydown. Base case uses 100% of predicted RCM uplift. Bull case: 130% uplift at lower entry. Bear case: 50% uplift at higher entry.

ScenarioEntryExitEquity InEquity OutMOICIRR
Base Case10.0x10.0x$-2.3M$56.0M0.00x-100.0%
Base (11x exit)10.0x11.0x$-2.3M$60.9M0.00x-100.0%
Bull Case9.0x11.0x$-2.1M$81.8M0.00x-100.0%
Bull (12x exit)9.0x12.0x$-2.1M$88.7M0.00x-100.0%
Bear Case11.0x10.0x$-2.5M$23.8M0.00x-100.0%
Bear (11x exit)11.0x11.0x$-2.5M$25.4M0.00x-100.0%

7. Key Risks & Mitigants

SeverityRisk FactorMitigant
HighNegative operating marginRCM uplift bridge shows clear path to profitability; working capital release provides near-term cash cushion

8. Data Sources & Methodology Appendix

Data Sources

  • CMS HCRIS Cost Reports (Medicare-certified hospitals)
  • CMS Medicare Utilization (DRG-level volumes)
  • CMS Chronic Conditions (county-level disease prevalence)
  • HCRIS multi-year trend data (financial time series)

Comparable Selection

  • 64 hospitals with 18-74 beds
  • Same-state prioritization (n=65)
  • Comp margins: P25=-8.4% / P50=-3.1% / P75=2.4%

Bridge Methodology

  • Targets: P75 of comparable peers (60% gap closure)
  • Denial: avoidable share = 35% of delta × NPR
  • AR: bad debt coefficient = $0.65 per day per $1K NPR
  • NCR: 60% coefficient on collection rate improvement
  • CDI: 0.75% of Medicare revenue per 0.01 CMI point

Returns Assumptions

  • Leverage: 5.5x entry (84.6% debt / 15.4% equity)
  • Organic growth: 3% annual EBITDA growth
  • Debt paydown: 10% of principal per year
  • Hold period: 5 years

Generated by SeekingChartis on April 26, 2026. All predictions use public data only. Confidence intervals calibrated via split conformal prediction (90% coverage target). This memo is for informational purposes and does not constitute investment advice.